Type 2 diabetes Trials in Dearborn, United States
Conditions / Type 2 diabetes / Dearborn, United States
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06045221 | A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin | COMPLETED | PHASE3 |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk | COMPLETED | — |
| NCT00942188 | A Study of LY2189102 in Patients With Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT00263276 | A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 |
| NCT02058160 | Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02058147 | Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM | COMPLETED | PHASE3 |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone | COMPLETED | — |
| NCT00658021 | Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00698789 | Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes | TERMINATED | PHASE2 |
| NCT01768559 | Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients | COMPLETED | PHASE3 |